• Vibrating Pill Could Both Treat Eating Disorders and Predict Relapse

    Jul 22 | Diagnostics World | Digestive sensations profoundly affect mental health through the bidirectional gut-brain axis, and in the case of anorexia nervosa (AN) tends to do so at crisis proportions. The disorder has one of the highest mortality rates of any psychiatric disorder with suicide being the leading cause of death. More

  • Nanotechnology for Point-of-Care Screening of Gut Health

    Jul 21 | Diagnostics World | Indole-3-propionic acid (IPA) is increasingly recognized as a critical chemical shield and promising biomarker for gut inflammation. Levels of IPA are starkly deficient in the blood of patients with active ulcerative colitis (UC), but the gold standard measurement technique of liquid chromatography-mass spectrometry (LC-MS) is costly and requires highly trained technicians to run the equipment, limiting its use to specialized research cohorts and clinical trials. More

  • Epi One Aims to ‘Democratize’ Early Detection One Cancer at a Time

    Jul 16 | Diagnostics World | Much like the trajectory of infectious disease diagnostics was changed by PCR and molecular methods, Epi One is looking to alter the course of cancer diagnostics with direct, highly sensitive molecular detection of specific epigenetic biomarkers of multiple malignancies. First out of the gate will be a prostate cancer re-biopsy decision tissue-based assay, immediately followed by an initial prostate cancer biopsy blood-based test. More

  • New Alzheimer’s Blood Test Flags Symptom Onset

    Jul 14 | Diagnostics World | Researchers from Washington University School of Medicine, St. Louis have showed that elevated levels of a set of circular RNAs (circRNAs) in the blood nearly tripled patients’ risk of developing Alzheimer’s Disease (AD) symptoms, suggesting these molecules are more sensitive to symptom onset than traditional AD biomarkers. More

  • Risk for Lung Cancer Written in the Blood

    Jul 09 | Diagnostics World | Researchers in London have identified a 14-protein blood signature predictive of lung cancer risk more than five years before a clinical diagnosis. If the proteomics panel makes its way to routine clinical practice, it could prove invaluable in flagging individuals likely to benefit from preventive screening. More

  • AI Interprets 3D Eye Scans to Improve Diagnoses, Speed up Trials

    Jul 08 | Diagnostics World | Thanks to several key advances in deep learning architecture, optical coherence tomography (OCT)—one of the most obtained medical images in the world—can now be used to predict disease one patient at a time. The people who stand to benefit are not only those suffering from common retinal diseases, but also conditions such as heart attack, stroke, and kidney failure simply by analyzing microscopic features in the eye. More

  • Digital Brain Twin Tailor-Made for Autism Spectrum Disorder

    Jul 07 | Diagnostics World | A new type of digital twin model of the brain, designed specifically for children with autism spectrum disorder, has been developed by researchers in Italy in hopes of enabling targeted treatment with transcranial magnetic stimulation at the exact location in the brain where neural circuits are misfiring. More

  • Follow the Money: Early Cancer Detection, Slowed Aging Medications, Expanding Life Science Labs

    Jul 01 | Diagnostics World | Spot Biosystems emerged from stealth and published a study on Duchenne muscular dystrophy; NewLimit aims to accelerate liver recovery from injury and improve tolerance of dietary and alcohol-related stress in preclinical models; and more. More

  • Sanofi, Pangaea Data Partnership, 10x Genomics Collaborates with Cleveland Clinic, Rapid Test for Acute Ischemic Stroke

    Jun 30 | Diagnostics World | Labcorp announced the nationwide availability of ColoSense; Hartwig Medical Foundation and Ultima Genomics announce an expansion of their strategic collaboration; the University of Texas MD Anderson Cancer Center join a global consortium dedicated to eliminating cervical cancer worldwide; and more. More

  • Cancer Patient’s Genetic Ancestry Helps Predict Survival

    Jun 25 | Diagnostics World | Research presented at the annual conference of the European Society of Human Genetics shows that a cancer patient’s genetic ancestry can have a significant effect both on how their disease progresses and their survival. In the largest study of its kind, researchers examined nearly 1,900 specific genetic changes in tumors in order to measure whether certain mutations were more common in patients with different historic geographic origins. More
View more articles

 
DXX-Industry-spotlight

merck


Custom Diagnostic Antibody Development & Manufacturing Services

Overcome Process Challenges by outsourcing your custom antibody production to us. How partnering with an antibody production expert can improve your assay, accelerate launch, and maintain your manufacturing.

Learn more